Recent examples on the clinical relevance of the CYP2D6 polymorphism and endogenous functionality of CYP2D6

S Haertter - Drug metabolism and drug interactions, 2013 - degruyter.com
Abstract The cytochrome P450 2D6 (CYP2D6) belongs to a group of CYPs considered of
utmost importance in the metabolism of xenobiotics. Despite being of only minor abundance …

Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates

MM Jukić, RL Smith, E Molden… - Clinical …, 2021 - Wiley Online Library
The metabolic activity of the polymorphic CYP2D6 enzyme is dependent on the CYP2D6
genotype; however, the guidelines for translating the genotype into phenotype, which are of …

Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution

D Marez, M Legrand, N Sabbagh… - Pharmacogenetics …, 1997 - journals.lww.com
The polymorphic cytochrome P450 CYP2D6 is involved in the metabolism of various drugs
of wide therapeutic use and is a presumed susceptibility factor for certain environmentally …

PharmVar GeneFocus: CYP2D6

C Nofziger, AJ Turner, K Sangkuhl… - Clinical …, 2020 - Wiley Online Library
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly
polymorphic human CYP2D6 gene locus. CYP2D6 genetic variation impacts the metabolism …

[HTML][HTML] Will pharmacogenomics guide clinical practice?

J Licinio, I Alvarado, ML Wong - The Pharmacogenomics Journal, 2002 - nature.com
Very seldom has a field been launched at a more auspicious time. Pharmacogenomics
emerged as the sequencing of the human genome was nearly complete, as DNA arrays …

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

M Ingelman-Sundberg - The pharmacogenomics journal, 2005 - nature.com
CYP2D6 is of great importance for the metabolism of clinically used drugs and about 20–
25% of those are metabolised by this enzyme. In addition, the enzyme utilises …

Importance of CYP2D6 genotype/activity testing and applications

JAG Agúndez, E García-Martin - 2014 - Taylor & Francis
The potential of pharmacogenomic biomarkers has been extensively investigated in recent
years. Because polymorphisms in genes coding for drug-metabolizing enzymes are a major …

Availability of CYP2D6 Genotyping Results in General Practitioner and Community Pharmacy Medical Records

M Simoons, H Mulder, RA Schoevers, HG Ruhé… - …, 2017 - Taylor & Francis
Aim: To investigate the availability of CYP450–2D6 (CYP2D6) genotyping results in general
practitioner (GP) and/or community pharmacy records, and the influence thereof on …

CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic …

Panserat, Sica, Gérard, Mathieu… - British journal of …, 1999 - Wiley Online Library
Aims To determine the molecular basis of the intermediate extensive metaboliser (EM)
CYP2D6 phenotype in healthy Gabonese subjects. Methods The CYP2D6 phenotype of 154 …

[HTML][HTML] Allele drop out conferred by a frequent CYP2D6 genetic variation for commonly used CYP2D6* 3 genotyping assays

G Scantamburlo, K Tziolia, M Zopf… - Cellular physiology and …, 2017 - karger.com
Background/Aim: Accurate genotyping of CYP2D6 is challenging due to its inherent genetic
variation, copy number variation (duplications and deletions) and hybrid formation with …